Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists
TXMD

TXMD - TherapeuticsMD Inc Stock Price, Fair Value and News

1.83USD+0.04 (+2.23%)Market Closed

Market Summary

TXMD
USD1.83+0.04
Market Closed
2.23%

TXMD Stock Price

View Fullscreen

TXMD RSI Chart

TXMD Valuation

Market Cap

21.1M

Price/Earnings (Trailing)

-2.85

Price/Sales (Trailing)

16.12

EV/EBITDA

-3.22

Price/Free Cashflow

-1.44

TXMD Price/Sales (Trailing)

TXMD Profitability

EBT Margin

-479.34%

Return on Equity

-25.85%

Return on Assets

-17.6%

Free Cashflow Yield

-69.22%

TXMD Fundamentals

TXMD Revenue

Revenue (TTM)

1.3M

Rev. Growth (Yr)

27.9%

Rev. Growth (Qtr)

6.92%

TXMD Earnings

Earnings (TTM)

-7.4M

Earnings Growth (Yr)

79.63%

Earnings Growth (Qtr)

16.87%

Breaking Down TXMD Revenue

Last 7 days

-0.5%

Last 30 days

6.4%

Last 90 days

-1.6%

Trailing 12 Months

-54.0%

How does TXMD drawdown profile look like?

TXMD Financial Health

Current Ratio

1.78

TXMD Investor Care

Shares Dilution (1Y)

12.37%

Diluted EPS (TTM)

-0.67

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202352.8M35.6M18.5M1.3M
202267.8M45.1M57.5M70.0M
202172.5M84.8M90.9M87.0M
202058.0M62.6M58.2M64.9M
201916.3M18.6M38.8M49.6M
201816.6M16.1M15.1M16.1M
201718.4M18.3M17.1M16.8M
201620.6M20.2M20.5M19.4M
201516.7M17.8M18.8M20.1M
201410.3M11.7M13.6M15.0M
201305.5M7.1M8.8M
20122.3M2.6M3.1M3.8M
20111.5M1.7M1.9M2.1M
20100001.2M
TXMD
TherapeuticsMD, Inc. operates as a pharmaceutical company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY,BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands. The company sells its prescription pharmaceutical products and prenatal vitamin products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.
 WEBSITEtherapeuticsmd.com
 INDUSTRYPharmaceuticals
 EMPLOYEES1

TherapeuticsMD Inc Frequently Asked Questions


What is the ticker symbol for TherapeuticsMD Inc? What does TXMD stand for in stocks?

TXMD is the stock ticker symbol of TherapeuticsMD Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of TherapeuticsMD Inc (TXMD)?

As of Fri Jul 26 2024, market cap of TherapeuticsMD Inc is 21.1 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of TXMD stock?

You can check TXMD's fair value in chart for subscribers.

Is TherapeuticsMD Inc a good stock to buy?

The fair value guage provides a quick view whether TXMD is over valued or under valued. Whether TherapeuticsMD Inc is cheap or expensive depends on the assumptions which impact TherapeuticsMD Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for TXMD.

What is TherapeuticsMD Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Jul 26 2024, TXMD's PE ratio (Price to Earnings) is -2.85 and Price to Sales (PS) ratio is 16.12. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. TXMD PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on TherapeuticsMD Inc's stock?

In the past 10 years, TherapeuticsMD Inc has provided -0.384 (multiply by 100 for percentage) rate of return.